Making Composite Time Trade-Off Sensitive for Worse-than-Dead Health States.

IF 4.4 3区 医学 Q1 ECONOMICS
PharmacoEconomics Pub Date : 2025-06-01 Epub Date: 2025-02-26 DOI:10.1007/s40273-025-01471-6
Michał Jakubczyk, Bram Roudijk, Stefan A Lipman, Peep Stalmeier
{"title":"Making Composite Time Trade-Off Sensitive for Worse-than-Dead Health States.","authors":"Michał Jakubczyk, Bram Roudijk, Stefan A Lipman, Peep Stalmeier","doi":"10.1007/s40273-025-01471-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The utilities elicited with the composite time trade-off (cTTO) method for health states worse-than-dead (WTD) often correlate poorly with other severity measures, indicating a poor sensitivity of cTTO. We aimed to explore modifications to cTTO to better understand this phenomenon and identify potential improvements.</p><p><strong>Methods: </strong>A total of 480 respondents completed an online TTO interview, each valuing 12 EQ-5D-5L health states. The participants were randomized into four arms, A-D. Arm A followed the standard cTTO, serving as a reference. In arm B, we removed the sorting question comparing immediate death versus 10 years in a valued state. Arm C allowed for utility values <math><mrow><mo><</mo> <mo>-</mo> <mn>1</mn></mrow> </math> by reducing the time in the valued state in the lead-time TTO (LT-TTO) part of cTTO. In arm D, we randomly selected the starting negative utility in LT-TTO. Utility value distributions, correlations between utilities and level sum score (LSS), and inconsistencies between Pareto-ordered states were analyzed.</p><p><strong>Results: </strong>Arm A replicated the lack of significant correlation between LSS and the negative utility observed in previous work. Of the experimental arms, only arm B exhibited a significant negative correlation. Compared with arm A, arm B produced a higher proportion of WTD states ( <math><mrow><mn>46.5</mn> <mo>%</mo></mrow> </math> versus  <math><mrow><mn>26.3</mn> <mo>%</mo></mrow> </math> ), less negative utility for WTD states on average ( <math><mrow><mo>-</mo> <mn>0.571</mn></mrow> </math> versus  <math><mrow><mo>-</mo> <mn>0.752</mn></mrow> </math> ), and a lower mean censored utility for 55555 ( <math><mrow><mo>-</mo> <mn>0.486</mn></mrow> </math> versus  <math><mrow><mo>-</mo> <mn>0.406</mn></mrow> </math> ).</p><p><strong>Conclusions: </strong>The observed lack of correlation between LSS and utility for WTD states appears linked to the use of comparison with immediate death in the sorting question. LT-TTO is capable of eliciting utility values in a way that is sensitive to severity. Modifying the initial questions in cTTO to identify whether health states are BTD or WTD should be considered.</p>","PeriodicalId":19807,"journal":{"name":"PharmacoEconomics","volume":" ","pages":"665-675"},"PeriodicalIF":4.4000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12081533/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40273-025-01471-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The utilities elicited with the composite time trade-off (cTTO) method for health states worse-than-dead (WTD) often correlate poorly with other severity measures, indicating a poor sensitivity of cTTO. We aimed to explore modifications to cTTO to better understand this phenomenon and identify potential improvements.

Methods: A total of 480 respondents completed an online TTO interview, each valuing 12 EQ-5D-5L health states. The participants were randomized into four arms, A-D. Arm A followed the standard cTTO, serving as a reference. In arm B, we removed the sorting question comparing immediate death versus 10 years in a valued state. Arm C allowed for utility values < - 1 by reducing the time in the valued state in the lead-time TTO (LT-TTO) part of cTTO. In arm D, we randomly selected the starting negative utility in LT-TTO. Utility value distributions, correlations between utilities and level sum score (LSS), and inconsistencies between Pareto-ordered states were analyzed.

Results: Arm A replicated the lack of significant correlation between LSS and the negative utility observed in previous work. Of the experimental arms, only arm B exhibited a significant negative correlation. Compared with arm A, arm B produced a higher proportion of WTD states ( 46.5 % versus  26.3 % ), less negative utility for WTD states on average ( - 0.571 versus  - 0.752 ), and a lower mean censored utility for 55555 ( - 0.486 versus  - 0.406 ).

Conclusions: The observed lack of correlation between LSS and utility for WTD states appears linked to the use of comparison with immediate death in the sorting question. LT-TTO is capable of eliciting utility values in a way that is sensitive to severity. Modifying the initial questions in cTTO to identify whether health states are BTD or WTD should be considered.

使比死亡更糟糕的健康状态的复合时间权衡敏感。
目的:复合时间权衡(cTTO)方法对健康状态差于死亡(WTD)的效用通常与其他严重程度测量相关性较差,表明cTTO的敏感性较差。我们的目的是探索对cTTO的修改,以更好地理解这一现象并确定可能的改进。方法:480名受访者完成在线TTO访谈,每人评估12项EQ-5D-5L健康状态。参与者被随机分为四组,a组和d组。Arm A遵循标准cTTO,作为参考。在B组中,我们去掉了比较立即死亡和处于有价值状态10年的排序问题。Arm C通过减少cTTO的前置时间TTO (LT-TTO)部分中处于有值状态的时间,从而允许效用值- 1。在D组中,我们随机选择LT-TTO的起始负效用。分析了效用值分布、效用与水平和分数(LSS)之间的相关性以及帕累托有序状态之间的不一致性。结果:Arm A重复了先前工作中观察到的LSS与负效用之间缺乏显著相关性。实验组中,只有B组表现出显著的负相关。与A组相比,B组产生了更高比例的WTD状态(46.5%对26.3%),WTD状态的平均负效用更少(- 0.571对- 0.752),55555的平均截尾效用更低(- 0.486对- 0.406)。结论:观察到的LSS和WTD状态的效用之间缺乏相关性似乎与在分类问题中使用与立即死亡的比较有关。LT-TTO能够以一种对严重性敏感的方式得出效用值。修改cTTO中的初始问题,以确定健康状态是BTD还是WTD。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
PharmacoEconomics
PharmacoEconomics 医学-药学
CiteScore
8.10
自引率
9.10%
发文量
85
审稿时长
6-12 weeks
期刊介绍: PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative and practical articles on the application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes. An invaluable source of applied pharmacoeconomic original research and educational material for the healthcare decision maker. PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to patient care and drug utilization. PharmacoEconomics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信